The FDA's approval of Pfizer's maternal RSV vaccine has omitted key data and is problematic
Sensible Medicine
SEPTEMBER 2, 2023
In this guest post, Dave Allely, medical student, takes a deep dive into the data around Pfizer’s maternal RSV vaccine. There is no question that if kids are better off overall with the vaccine, we ought to give it. Perhaps the decision varies between women who want to breastfeed vs those who don’t, but net benefit is the key question. The problem is that the FDA and Pfizer have not provided data to assess net benefit.
Let's personalize your content